Labcorp Holdings Inc
LH261.120USD
-0.530-0.20%
Close 06/13, 16:00（ET）Quotes delayed by 15 min
21.88BMarket Cap
29.33P/E TTM
More Details of Labcorp Holdings Inc Company
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Company Info
Ticker SymbolLH
Company nameLabcorp Holdings Inc
IPO dateApr 24, 1991
Founded at2024
CEOMr. Adam H. Schechter
Number of employees70000
Security typeOrdinary Share
Fiscal year-endApr 24
Address358 S Main St
CityBURLINGTON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code27215
Phone13362291127
Websitehttps://www.labcorp.com/
Ticker SymbolLH
IPO dateApr 24, 1991
Founded at2024
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
98.96K
-5.81%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-6.24%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
12.67K
-3.80%
Ms. Richelle P. Parham
Ms. Richelle P. Parham
Independent Director
Independent Director
9.48K
--
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
5.30K
+16.66%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
4.96K
--
Mr. Akinbolade Oyegunwa
Mr. Akinbolade Oyegunwa
Executive Vice President and Chief Information and Technology Officer
Executive Vice President and Chief Information and Technology Officer
3.46K
+16.48%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
98.96K
-5.81%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-6.24%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
12.67K
-3.80%
Revenue Breakdown
Currency: USDUpdated: Wed, Mar 12
Currency: USDUpdated: Wed, Mar 12
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
Northern America
13.09B
81.22%
Europe
2.05B
12.72%
Other Countries
976.40M
6.06%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.57%
BlackRock Institutional Trust Company, N.A.
5.50%
State Street Global Advisors (US)
4.57%
Select Equity Group, L.P.
2.65%
Geode Capital Management, L.L.C.
2.47%
Other
73.23%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.57%
BlackRock Institutional Trust Company, N.A.
5.50%
State Street Global Advisors (US)
4.57%
Select Equity Group, L.P.
2.65%
Geode Capital Management, L.L.C.
2.47%
Other
73.23%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
45.39%
Investment Advisor
41.36%
Research Firm
3.23%
Pension Fund
2.08%
Hedge Fund
1.82%
Bank and Trust
1.44%
Sovereign Wealth Fund
1.31%
Individual Investor
0.39%
Insurance Company
0.06%
Other
2.91%
Institutional Shareholding
Updated: Mon, Jan 20
Updated: Mon, Jan 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
1833
81.30M
97.13%
-4.60M
2024Q4
1872
81.10M
96.90%
-5.32M
2024Q3
1856
80.09M
95.55%
-6.82M
2024Q2
1876
81.29M
96.43%
-7.49M
2024Q1
1904
82.39M
97.73%
-8.65M
2023Q4
1947
83.11M
99.02%
-9.76M
2023Q3
1930
84.34M
99.29%
-7.18M
2023Q2
1934
84.05M
94.75%
-3.56M
2023Q1
1940
82.33M
92.89%
-5.93M
2022Q4
1948
82.50M
93.48%
-7.69M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
9.62M
11.49%
+15.33K
+0.16%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
4.55M
5.43%
-7.51K
-0.16%
Dec 31, 2024
State Street Global Advisors (US)
3.70M
4.43%
-23.02K
-0.62%
Dec 31, 2024
Select Equity Group, L.P.
1.60M
1.91%
+959.98K
+150.95%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.00M
2.4%
+39.26K
+2.00%
Dec 31, 2024
Allspring Global Investments, LLC
1.92M
2.29%
+51.05K
+2.74%
Dec 31, 2024
Diamond Hill Capital Management Inc.
1.97M
2.35%
-11.59K
-0.59%
Dec 31, 2024
BlackRock Financial Management, Inc.
1.92M
2.3%
-131.53K
-6.40%
Dec 31, 2024
Nordea Funds Oy
1.05M
1.26%
+68.97K
+7.01%
Dec 31, 2024
Fidelity Management & Research Company LLC
1.21M
1.45%
+30.98K
+2.62%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
iShares U.S. Healthcare Providers ETF
3.67%
iShares Large Cap Value Active ETF
2.99%
Thrivent Small-Mid Cap ESG ETF
2.25%
SPDR S&P Health Care Services ETF
2.1%
Strategas Global Policy Opportunities ETF
2.02%
Knowledge Leaders Developed World ETF
1.99%
iShares Health Innovation Active ETF
1.93%
Invesco S&P 500 Equal Weight Health Care ETF
1.77%
Brandes US Value ETF
1.58%
First Trust Health Care Alphadex Fund
1.46%
View more
iShares U.S. Healthcare Providers ETF
Proportion3.67%
iShares Large Cap Value Active ETF
Proportion2.99%
Thrivent Small-Mid Cap ESG ETF
Proportion2.25%
SPDR S&P Health Care Services ETF
Proportion2.1%
Strategas Global Policy Opportunities ETF
Proportion2.02%
Knowledge Leaders Developed World ETF
Proportion1.99%
iShares Health Innovation Active ETF
Proportion1.93%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.77%
Brandes US Value ETF
Proportion1.58%
First Trust Health Care Alphadex Fund
Proportion1.46%
Dividend
A total of
692.30M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jan 09, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025
Feb 27, 2025
Mar 12, 2025
Feb 27, 2025
Oct 10, 2024
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024
Nov 26, 2024
Dec 13, 2024
Nov 26, 2024
Jul 25, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024
Aug 29, 2024
Sep 13, 2024
Aug 29, 2024
Apr 11, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024
May 28, 2024
Jun 12, 2024
May 24, 2024
Jan 12, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024
Feb 27, 2024
Mar 13, 2024
Feb 26, 2024
Oct 12, 2023
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Dec 12, 2023
Nov 07, 2023
Jul 13, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 08, 2023 going ex on Aug 07, 2023
Aug 08, 2023
Sep 08, 2023
Aug 07, 2023
Apr 06, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 08, 2023 going ex on May 17, 2023
May 18, 2023
Jun 08, 2023
May 17, 2023
Jan 12, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2023 going ex on Feb 22, 2023
Feb 23, 2023
Mar 13, 2023
Feb 22, 2023
Oct 12, 2022
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 09, 2022 going ex on Nov 16, 2022
Nov 17, 2022
Dec 09, 2022
Nov 16, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
